SARS-CoV-2 Mpro-IN-19
SARS-CoV-2 Mpro-IN-19 (compound MPI94) is a SARS-CoV-2 MPro inhibitor with the IC50 of 0.096 μM. SARS-CoV-2 Mpro-IN-19 can be used for study of COVID-19[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-mpro-in-19.html
Smiles
O=C(N1[C@H](C(N[C@@H](C[C@H]2C(NCC2)=O)C=O)=O)[C@@]3([H])C(C)(C)[C@@]3([H])C1)OC(C4=CC=CC=C4)C5=CC=CC=C5
Molecular Formula
C29H33N3O5
Molecular Weight
503.59
References & Citations
[1]Lauren R. Blankenship, et al. SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme. ACS Med. Chem. Lett. 2024, 15, 6, 950–957.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040026-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681970-100 1x 100 µL
Thyroglobulin (Thyroidal Cell Marker) (TGB/1970R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741063-100 1x 100 µL
VEGF-A (VEGF/1063), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041926-500 1x 500 µL
SOX9 / SRY-box 9 (PCRP-SOX9-1E5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040759-100 1x 100 µL
Human IgM Immunoglobulin (DA4-4), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details